Abstract Novel interventions for post-traumatic stress disorder (PTSD) leverage the psychoactive properties of psychedelic compounds, such as ketamine, 3,4-methylenedioxymethamphetamine and…
Abstract Purpose: To evaluate the current level of evidence for the use of psychedelics for the management of cancer pain…
Abstract Background: The Hallucinogen Rating Scale (HRS) has been widely used to measure the subjective effects of psychedelics and other…
Abstract The promises of the Prozac century have fallen short; the number of novel, therapeutically significant medications successfully completing development…
Abstract Introduction: Anorexia nervosa (AN) has one of the highest mortality rates of all mental illnesses. No approved pharmacological treatments…
Abstract Background: Most studies examining the simultaneous use of cannabis with other drugs have focused on cannabis and alcohol, with…
Abstract Objective: This study aims to provide an overview of pharmacological trials that examine the neurocognitive effects of psychedelics among…
Abstract Introduction: Cannabis use disorder (CUD) is prevalent in ~2–5% of adults in the United States and is anticipated to…
Abstract Hallucinations are currently associated almost exclusively with psychopathological states. While it is evident that hallucinations can indicate psychopathology or…
Abstract Psychiatric disorders associated with psychological trauma, stress and anxiety are a highly prevalent and increasing cause of morbidity worldwide.…